UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Number of items: 608.

A

Ah-See, MLW; Makris, A; Burcombe, RJ; Davies, C; Cladd, HJ; Padhani, AR; Harris, AL; (2003) Evaluation of plasma & serum vascular endothelial growth factor (VEGF) during neoadjuvant chemotherapy for primary breast cancer. British Journal of Cancer , 88 S44-S44.

Ah-See, MLW; Taylor, NJ; Makris, A; Burcombe, RJ; Stirling, JJ; Cladd, HJ; Leach, MO; (2003) Valuation of multi-functional dynamic contrast-enhanced MRI to predict response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 88 S41-S41.

Ahmad, H; Pawade, J; Pignatelli, M; Mangwana, S; Janghra, N; (2003) An audit of the role of PCR in lymphoma diagnosis. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 24A-24A). JOHN WILEY & SONS LTD

Ahmedzai, S; Hoskin, PJ; (2003) Assessment and management of malignant disease. In: Muers, MF, (ed.) Oxford Textbook: Supportive Care in Respiratory Disease. Oxford University Press: Oxford.

Ala, A; Dhillon, AP; Hodgson, HJ; (2003) Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. INT J EXP PATHOL , 84 (1) 1 - 16.

Allcock, RJN; Barrow, AD; Forbes, S; Beck, S; Trowsdale, J; (2003) The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. EUR J IMMUNOL , 33 (2) 567 - 577.

Alsowmely, A; Grasso, A; Hodgson, H; Burroughs, A; Davidson, B; Quaglia, A; Dhillon, A; (2003) Life-table analysis of survival after liver transplantation for hepatocellular carcinoma: A single centre study. In: (pp. 64-).

Alvi, AJ; Clayton, H; Joshi, C; Enver, T; Ashworth, A; Vivanco, MD; Dale, TC; (2003) Functional and molecular characterisation of mammary side population cells (vol 5, pg R1, 2003). BREAST CANCER RESEARCH , 5 (1) 10.1186/bcr563.

Alvi, AJ; Clayton, H; Joshi, C; Enver, T; Ashworth, A; Vivanco, MDM; Dale, TC; (2003) Functional and molecular characterisation of mammary side population cells. Breast Cancer Res , 5 (1) R1-R8.

Amadou, C; Younger, RM; Sims, S; Matthews, LH; Rogers, J; Kumanovics, A; Ziegler, A; (2003) Co-duplication of olfactory receptor and MHC class I genes in the mouse major histocompatibility complex. HUM MOL GENET , 12 (22) 3025 - 3040. 10.1093/hmg/ddg317.

Ameer-Beg, SM; Edme, N; Peter, M; Barber, PR; Ng, T; Vojnovic, B; (2003) Imaging protein-protein interactions by multiphoton FLIM. Proceedings of SPIE - The International Society for Optical Engineering , 5139 pp. 180-189.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, I; Linch, DC; (2003) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. BRIT J HAEMATOL , 120 (4) 685 - 690.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171. 10.1080/1024533031000107497.

Anilkumar, N; Parsons, M; Monk, R; Ng, T; Adams, JC; (2003) Interaction of fascin and protein kinase C alpha: a novel intersection in cell adhesion and motility. EMBO JOURNAL , 22 (20) pp. 5390-5402. 10.1093/emboj/cdg521.

Ann, F; (2003) Thalidomide: horror and redemption. Cancer Nursing Practice , 2 (25) pp. 10-12.

Ardeshna, K.M.; Smith, P.; Norton, A.; Hancock, B.W.; Hoskin, P.J.; MacLennan, K.A.; Marcus, R.E.; (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. The Lancet , 362 (9383) pp. 516-522. 10.1016/S0140-6736(03)14110-4.

Ardeshna, KM; Kakouros, N; Qian, WD; Powell, MG; Saini, N; D'Sa, S; Hoskin, PJ; (2003) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease in response to first line salvage chemotherapy regimens. In: BLOOD. (pp. 400A - 400A). AMER SOC HEMATOLOGY

Ardeshna, KM; Smith, P; Norton, A; Hancock, BW; Hoskin, PJ; MacLennan, KA; Marcus, RE; (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. LANCET , 362 (9383) 516 - 522.

Arkenau, H-T; Kruse, F; Jend, HH; Porschen, R; (2003) [Differential diagnosis of morbus Crohn disease: intussusception of the colon]. Z Gastroenterol , 41 (7) pp. 663-666. 10.1055/s-2003-40549.

Arkenau, HT; Bermann, A; Rettig, K; Strohmeyer, G; Porschen, R; Arbeitsgemeinschaft Gastrointestinale Onkologie, ; (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol , 14 (3) pp. 395-399.

Arkenau, HT; Kruse, F; Jend, HH; Porschen, R; (2003) Differential diagnosis of Morbus Crohns disease: Intussusception of the colon. Zeitschrift fur Gastroenterologie , 41 (7) pp. 663-666. 10.1055/s-2003-40549.

Arnett, TR; Massey, HM; Utting, JC; Orriss, IR; Flanagan, AM; (2003) Hypoxia is a major stimulator of osteoclast formation from human peripheral blood. In: (pp. pp. 345-346).

Assersohn, L; Salter, J; Powles, TJ; A'Hern, R; Makris, A; Gregory, RK; Chang, J; (2003) Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer. Breast Cancer Research and Treatment , 82 (2) pp. 113-123.

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Cufer, T; Coleman, R; Calvert, AH; (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. EUR J CANCER , 39 (17) 2439 - 2449. 10.1016/S0959-8049(03)00601-4.

Atteia, A; van Lis, R; Wetterskog, D; Gutiérrez-Cirlos, E-B; Ongay-Larios, L; Franzén, L-G; González-Halphen, D; (2003) Structure, organization and expression of the genes encoding mitochondrial cytochrome c(1) and the Rieske iron-sulfur protein in Chlamydomonas reinhardtii. Mol Genet Genomics , 268 (5) pp. 637-644. 10.1007/s00438-002-0779-x.

Attygalle, AD; Chuang, SS; Diss, TC; Hamoudi, RA; Munson, P; Du, MQ; Isaacson, PG; (2003) Nodal peripheral T-cell lymphomas: the role of CD10 in diagnosis. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 4A-4A). WILEY-BLACKWELL

B

BBC, NO; (2003) Blood test spots 'asbestos cancer'. UNSPECIFIED

BBC, NO; (2003) Scans help spot lung cancer early. UNSPECIFIED

BBC, NO; (2003) Thalidomide trials to fight cancer. UNSPECIFIED

BBC, NO; (2003) Warning to heed lung cancer signs. UNSPECIFIED

BBC, R4; (2003) Thalidomide Trial. UNSPECIFIED

Bain, BJ; Gupta, R; (2003) A-Z of haematology. [Book]. Wiley-Blackwell

Baker, RJ; Gerrard, G; Wickremasinghe, RG; Hoffbrand, AV; Mehta, AB; Ross, DD; Ganeshaguru, K; (2003) Expression of breast cancer resistance protein in malignant cells from patients with leukaemia. In: LEUKEMIA. (pp. 662 - 662). NATURE PUBLISHING GROUP

Baldeschi, C; Gache, Y; Rattenholl, A; Bouillé, P; Danos, O; Ortonne, J-P; Bruckner-Tuderman, L; (2003) Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet , 12 (15) pp. 1897-1905.

Balk, J; Chew, SK; Leaver, CJ; McCabe, PF; (2003) The intermembrane space of plant mitochondria contains a DNase activity that may be involved in programmed cell death. PLANT JOURNAL , 34 (5) pp. 573-583. 10.1046/j.1365-313X.2003.01748.x.

Barnes, EJ; Abdel-Rehim, MM; Goulis, Y; Abou Ragab, M; Davies, S; Dhillon, A; Davidson, B; (2003) Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. American Journal of Transplantation , 3 (4) pp. 432-438.

Barrie, SE; Eno-Amooquaye, E; Hardcastle, A; Platt, G; Richards, J; Bedford, D; Workman, P; (2003) High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Anal Biochem , 320 (1) pp. 66-74.

Bates, AW; (2003) "Author pays" publishing model - Not all authors will gain. BRIT MED J , 327 (7405) 53 - 53.

Bates, AW; (2003) Autopsy on a case of roberts syndrome reported in 1672: The earliest description? AM J MED GENET A , 117A (1) 92 - 96. 10.1002/ajmg.a.10864.

Bates, AW; (2003) The sooterkin dissected: the theoretical basis of animal births to human mothers in early modern Europe. Vesalius , 9 pp. 6-14.

Bates, AW; Sebire, NJ; Williams, S; Ramsay, AD; (2003) Variable antigen expression in Hepatoblastomas. In: JOURNAL OF PATHOLOGY. (pp. 42A - 42A). JOHN WILEY & SONS LTD

Beck, S; (2003) Immunogenomics: towards a digital immune system. Novartis Found Symp , 254 pp. 223-230.

Beck, S; (2003) The Human Genome Project: What we have learnt about the MHC region on chromosome 6 and its potential to Behcet's disease. ADAMANTIADES-BEHCET'S DISEASE , 528 207 - 211.

Benjamin, E; Isaacson, P; (2003) Lymphoproliferative disease of the female genital tract. In: Fox, H and Wells, M, (eds.) Obstetrical and Gynaecological Pathology. (pp. 935-962). Churchill Livingstone

Benjamin, R; Davidoff, AM; Ng, CYC; Pizzey, A; Yong, K; Nathwani, AC; (2003) Murine models of hematological malignancies that mimic the disease phenotype in humans. In: BLOOD. (pp. 888A - 888A). AMER SOC HEMATOLOGY

Bennett, CL; Colledge, L; Richards, HE; Reay, PA; Blackburn, CC; Aebischer, T; (2003) Uncompromised generation of a specific H-2DM-dependent peptide-MHC class II complex from exogenous antigen in Leishmania mexicana-infected dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 33 (12) pp. 3504-3513. 10.1002/eji.200323425.

Beresford, M; Glynne-Jones, R; Makris, A; Harrison, M; (2003) Lymph node staging following preoperative chemoradiation in rectal cancer. British Journal of Cancer , 88 S21-S21.

Bergamaschi, D; Gasco, M; Hiller, L; Sullivan, A; Syed, N; Trigiante, G; Yulug, I; (2003) p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell , 3 (4) pp. 387-402.

Berthoux, L; Towers, GJ; Gurer, C; Salomoni, P; Pandolfi, PP; Luban, J; (2003) As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J VIROL , 77 (5) 3167 - 3180. 10.1128/JVI.77.5.3167-3180.2003.

Bettencourt-Dias, M; Mittnacht, S; Brockes, JP; (2003) Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J CELL SCI , 116 (19) 4001 - 4009. 10.1242/jcs.00698.

Birtle, AJ; Freeman, A; Masters, JRW; Payne, HA; Harland, SJ; (2003) Clinical Features of Patients Who Present with Metastatic Prostate Carcinoma and Serum Prostate-Specific Antigen (PSA) Levels < 10 ng/mL: The "PSA Negative" Patients. Cancer , 98 (11) pp. 2362-2367. 10.1002/cncr.11821.

Bjedov, I; Lecointre, G; Tenaillon, O; Vaury, C; Radman, M; Taddei, F; Denamur, E; (2003) Polymorphism of genes encoding SOS polymerases in natural populations of Escherichia coli. DNA Repair (Amst) , 2 (4) pp. 417-426.

Bjedov, I; Tenaillon, O; Gérard, B; Souza, V; Denamur, E; Radman, M; Taddei, F; (2003) Stress-induced mutagenesis in bacteria. Science , 300 (5624) pp. 1404-1409. 10.1126/science.1082240.

Bogunia-Kubik, K; Natarajan, P; Brown, S; Wolley, J; Alcocer, M; Fallen, PR; Madrigal, JA; (2003) Cord blood serum affects T cells ability to produce and respond to IL-2. Cytokine , 22 (1-2) pp. 42-49.

Borthwick, NJ; Akbar, AA; Buckley, C; Pilling, D; Salmon, M; Jewell, AP; Yong, KL; (2003) Transendothelial migration confers a survival advantage to activated T lymphocytes: role of LFA-1/ICAM-1 interactions. CLIN EXP IMMUNOL , 134 (2) 246 - 252. 10.1046/j.1365-2249.2003.02298.x.

Boshoff, C; (2003) Kaposi virus scores cancer coup. NAT MED , 9 (3) 261 - 262. 10.1038/nm0303-261.

Boshoff, C; (2003) Kohn to Kaposi. NAT MED , 9 (3) 262 - 262. 10.1038/nm0303-262.

Bowen, DT; Frew, MEC; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; Langabeer, SE; (2003) RAS gene mutation in acute myeloid leukemia; Analysis of cases from the medical research council AML 10 and 12 clinical trials. In: BLOOD. (pp. 374A - 375A). AMER SOC HEMATOLOGY

Bowles, L; Cohen, H; (2003) Inherited thrombophilias and anticoagulation in pregnancy. BEST PRACT RES CL OB , 17 (3) 471 - 489. 10.1053/S1521-6934(03)00012-9.

Boyle, P; Autier, P; Bartelink, H; Baselga, J; Boffetta, P; Burn, J; Burns, HJG; (2003) European Code Against Cancer and scientific justification: third version (2003). ANN ONCOL , 14 (7) 973 - 1005. 10.1093/annonc/mdg305.

Brada, M; Viviers, L; Abson, C; Hines, F; Britton, J; Ashley, S; Sardell, S; (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol , 14 (12) pp. 1715-1721.

Braithwaite, D; Sutton, S; Mackay, J; Stein, J; Hopkinson, I; Emery, J; (2003) UNSPECIFIED In: (Proceedings) 'Computer support for genetic risk assessment and advice about breast cancer susceptibility: a feasibility study of patient self-assessment in a family history clinic'. In AACR Frontiers in Cancer Prevention, Phoenix, Arizona, 26-30 October.

Brissault, B; Kichler, A; Guis, C; Leborgne, C; Danos, O; Cheradame, H; (2003) Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjug Chem , 14 (3) pp. 581-587. 10.1021/bc0200529.

Brookman-Amissah, N; Price, RK; Foxon, R; Mackay, A; O'Hare, MJ; Stein, RC; (2003) The effects of estradiol and ICI 182,780 treatment of primary breast cancer cells on gene transcription and comparison to effects in established cell lines. In: (Proceedings) British Cancer Research Meeting 2003. (pp. S49-S49). NATURE PUBLISHING GROUP

Brookman-Amissah, N; Price, RK; Foxon, R; Zvelebil, MJ; Mackay, A; O'Hare, MJ; Stein, RC; (2003) The effects of estradiol and fulvestrant on gene expression in primary breast cancer cells and in established breast cell lines. In: (Proceedings) 26th Annual San Antonio Breast Cancer Symposium. (pp. S112-S112). SPRINGER

Brooks, A; Clingan, P; Morris, D; (2003) Hepatic artery chemotherapy and colorectal liver metastases. Lancet , 361 (9370) 1742-. 10.1016/S0140-6736(03)13340-5.

Brown, SA; Yee, TT; Griffioen, A; Lee, CA; (2003) Comparative study of full-length and B-domain deleted factor VIII concentrates. HAEMOPHILIA , 9 (6) 745 - 745.

Bucheit, AD; Kumar, S; Grote, DM; Lin, YK; von Messling, V; Cattaneo, RB; Fielding, AK; (2003) An oncolytic measles virus engineered to enter cells through the CD20 antigen. MOLECULAR THERAPY , 7 (1) pp. 62-72. 10.1016/S1525-0016(02)00033-3.

Burcombe, RJ; Makris, A; Pittam, M; Finer, N; (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast , 12 (4) pp. 290-293.

Burk, K; (2003) The Ageing Wine-Drinker. Prospect (10/2003) p. 50.

Burk, K; (2003) Anything But Chardonnay. Prospect (6/2003) p. 58.

Burk, K; (2003) Corks Versus Screwtops. Prospect (1/2003) p. 18.

Burk, KM; (2003) Anglo-American Relations before they were 'Special'. In: Capet, A and Sy-Wonyu, A, (eds.) The 'Special Relationship'. La 'relation spéciale' entre le Royaume Uni et les Etats Unis. (pp. 3-17). Publications de l'université de Rouen: Rouen.

C

Calabrese, CR; Batey, MA; Thomas, HD; Durkacz, BW; Wang, LZ; Kyle, S; Skalitzky, D; (2003) Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. CLIN CANCER RES , 9 (7) 2711 - 2718.

Calvert, H; (2003) Developing drugs for cancer: Striking balance between clinical pragmatism and scientific allure. In: BRITISH JOURNAL OF CANCER. (pp. S7 - S7). NATURE PUBLISHING GROUP

Calvert, H; (2003) Pemetrexed (Alimta): A promising new agent for the treatment of breast cancer. SEMINARS IN ONCOLOGY , 30 (2) 2 - 5. 10.1053/sonc.2003.37267.

Camilleri, ; Cohen, H; (2003) Venous thromboembolism and the -455F/A b-fibrinogen polymorphism. In: (Proceedings) International society of thrombosis and haemostasis.

Camilleri, RS; Mackie, IJ; Humphries, SE; Machin, SJ; Cohen, H; (2003) Lack of association of beta 2-glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications. BRIT J HAEMATOL , 120 (6) 1066 - 1072.

Carnell, D; Smith, R; Taylor, J; Stirling, J; Hoskin, P; Padhani, A; (2003) Evaluation of hypoxia within human prostate carcinoma using quantified bold MRI and pimonidazole immunohistochemical mapping. British Journal of Cancer , 88 S12-S12.

Carnell, DM; Daley, FM; Smith, RE; Hoskin, P; Murray, GI; Everett, SA; (2003) CYP1B1 protein expression in prostate carcinoma. British Journal of Cancer , 88 S34-S34.

Catherine, E; (2003) Thalidomide used in trials to cure cancer. Camden New Journal 25-.

Cecilioni, L; Stigliano, R; Leandro, G; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; (2003) Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population. In: (pp. 452-).

Cecilioni, L; Stigliano, R; Leandro, G; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; (2003) Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population. In: HEPATOLOGY. (pp. 379A - 379A). W B SAUNDERS CO

Chakrabarti, S; Mackinnon, S; (2003) The relevance of nonmyeloablative transplants in developing countries: Lessons from the UK experience. In: TRANSPLANTATION PROCEEDINGS. (pp. 172 - 173). ELSEVIER SCIENCE INC

Chakrabarti, S; Milligan, DW; Pillay, D; Mackinnon, S; Holder, K; Kaur, N; McDonald, D; (2003) Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. BLOOD , 102 (3) 839 - 842.

Chakraborty, R; Rees, G; Bourboulia, D; Cross, AM; Dixon, JR; D'Agostino, A; Musoke, R; (2003) Viral coinfections among African children infected with human immunodeficiency virus type 1. CLIN INFECT DIS , 36 (7) 922 - 924.

Chantret, I; Dancourt, J; Dupré, T; Delenda, C; Bucher, S; Vuillaumier-Barrot, S; Ogier de Baulny, H; (2003) A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem , 278 (11) pp. 9962-9971. 10.1074/jbc.M211950200. Gold open access

Chatterjee, R; Shah, F; Byers, MEAB; Sooranna, S; Bajoria, R; Pringle, JAS; Porter, JB; (2003) Prospective study of histomormometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteoporosis. In: BLOOD. (pp. 266A - 266A). AMER SOC HEMATOLOGY

Chelvatheebam, S; Langabeer, SE; Linch, DC; Hills, RK; Greenwell, P; (2003) Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia. LEUKEMIA RES , 27 (9) 869 - 870. 10.1016/S0145-2126(03)00016-X.

Chen, FE; Dodi, AI; Travers, PJ; Madrigal, AJ; (2003) Age dependent differentiation status of virus specific CTL - Immunological implications of age as a risk factor in SCT. BLOOD , 102 (11) 2582-.

Chicken, DW; Leel, AC; Pickard, CDO; Falzon, M; Bown, SG; Yu, RC; Scarisbrook, J; (2003) Optical biopsy - a novel perioperative diagnostic tool in surgical oncology. In: BRITISH JOURNAL OF SURGERY. (pp. 35 - 35). JOHN WILEY & SONS LTD

Chuah, C; Tipping, AJ; Goldman, JM; Melo, JV; (2003) Zoledronate is active against imatinib mesylate-resistant chronic myeloid leukemia cell lines and synergistic/additive when combined with imatinib mesylate. In: BLOOD. (pp. 19A - 19A). AMER SOC HEMATOLOGY

Chuang, S-S; Lee, C; Hamoudi, RA; Liu, H; Lee, P-S; Ye, H; Diss, TC; (2003) High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation. Br J Haematol , 120 (1) pp. 97-100.

Ciocchetta, F; Dell'Anna, R; Demichelis, F; Dhillon, AP; Quaglia, A; Sboner, A; (2003) Combining supervised and unsupervised methods to support early diagnosis of hepatocellular carcinoma. In: Dojat, M and Keravnou, E and Barahona, P, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 239 - 243). SPRINGER-VERLAG BERLIN

Ciocchetta, F; Dell'Anna, R; Demichelis, F; Sboner, A; Dhillon, AP; Dhillon, A; Godfrey, A; (2003) Knowledge discovery in support of early diagnosis of hepatocelluar carcinoma. In: PROCEEDINGS OF THE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS 2003, VOLS 1-4. (pp. 177 - 181). IEEE

Clark, J; Edwards, S; Feber, A; Flohr, P; John, M; Giddings, I; Crossland, S; (2003) Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. ONCOGENE , 22 (8) 1247 - 1252. 10.1038/sj.onc.1206247.

Clingen, PH; DeSilva, IU; Ghadessy, FJ; Thurston, DE; Hartley, JA; (2003) The role of nucleotide excision repair and homologous recombination in the sensitivity of mammalian cells to the minor groove crosslinking pyrrolo[2,1-c][1,4]benzodiazepine dimmer SJG-136(NSC694501). In: (pp. 2672-).

Coeytaux, E; Coulaud, D; Le Cam, E; Danos, O; Kichler, A; (2003) The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem , 278 (20) pp. 18110-18116. 10.1074/jbc.M300248200. Gold open access

Cohen, H; (2003) How to stimulate active participation in haemovigilance. In: (Proceedings) European haemovigilance network.

Cohen, H; (2003) SHOT - the future. [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Stainsby, D; (2003) The 2001/2002 annual SHOT Report (on behalf of the serious hazards of transfusion steering group).

Colombo, N; du Bois, A; Kristensen, G; Ledermann, J; Torri, V; (2003) ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit - Reply. LANCET , 362 (9392) p. 1334. 10.1016/S0140-6736(03)14604-1.

Corrie, P; Spanswick, VJ; Sehmbi, R; Jonson, A; Shaw, J; Dowen, S; Biswas, S; (2003) Increased persistence of treosulfan-induced DNA interstrand crosslinks when combined with gemcitabine: Proof of principle within a phase I trial. In: (pp. 128-).

Corsini, E; Viviani, B; Zancanella, O; Lucchi, L; Visioli, F; Serrero, G; Bartesaghi, S; (2003) Induction of adipose differentiation related protein and neutral lipid droplet accumulation in keratinocytes by skin irritants. J INVEST DERMATOL , 121 (2) 337 - 344.

Corsini, E; Zancanella, O; Lucchi, L; Visioli, E; Viviani, B; Bartesaghi, S; Marinovich, M; (2003) Induction of adipose differentiation related protein and neutral lipid droplets accumulation in keratinocytes by skin irritants. In: TOXICOLOGICAL SCIENCES. (pp. 382 - 382). OXFORD UNIV PRESS

Cox, ST; McWhinnie, AJ; Robinson, J; Marsh, SGE; Parham, P; Madrigal, JA; Little, AM; (2003) Cloning and sequencing full-length HLA-B and -C genes. TISSUE ANTIGENS , 61 (1) pp. 20-48. 10.1034/j.1399-0039.2003.610103.x.

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Selden, C; Sim, R; North, J; (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: JOURNAL OF PATHOLOGY. (pp. 2A - 2A). JOHN WILEY & SONS LTD

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; North, J; (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: (pp. 109-).

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; North, J; (2003) Hepatocyte progenitor cells in massive hepatic necrosis. JOURNAL OF HEPATOLOGY , 38 38 - 38.

Crowley, J; Hagan, R; Clancy, D; Rooney, G; Dunne, C; Lawlor, E; Hayden, P; (2003) Two sets of HLA class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Antigens , 61 pp. 487-491.

Crowley, J; Hagan, R; Clancy, D; Rooney, G; Dunne, C; Lawlor, E; Hayden, P; (2003) Two sets of HLA class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Antigens , 61 pp. 487-491.

D

D'Sa, S; Kyriakou, C; Bhattacharya, S; Peggs, K; Foulkes, B; Ings, S; Watts, M; (2003) Etoposide, methylprednisolone, cytarabine and cisplatin (ESHAP) can cytoreduce resistant myeloma patients and mobilise them for transplant without adverse effects. In: BLOOD. (pp. 688A - 688A). AMER SOC HEMATOLOGY

D'Sa, S; Peggs, K; Pizzey, A; Verfuerth, S; Thuraisundaram, D; Watts, M; White, H; (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. British Journal of Haematology , 123 (2) pp. 309-322. 10.1046/j.1365-2141.2003.04612.x.

D'Sa, S; Peggs, K; Pizzey, A; Verfuerth, S; Thuraisundaram, D; Watts, M; White, H; (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. BRIT J HAEMATOL , 123 (2) 309 - 322.

Daly, ME; Makris, A; Reed, M; Lewis, CE; (2003) Hemostatic regulators of tumor angiogenesis: A source of antiangiogenic agents for cancer treatment? Journal of the National Cancer Institute , 95 (22) pp. 1660-1673.

Damien, E; Hing, K; Saeed, S; Revell, PA; (2003) A preliminary study on the enhancement of the osteointegration of a novel synthetic hydroxyapatite scaffold in vivo. Journal of Biomedical Materials Research Part A , 66A (2) pp. 241-246.

Dangoor, A; Ranson, M; Lee, SM; Beech, J; Sherlock, DJ; Wilkinson, PM; Valle, JW; (2003) Treatment of inoperable hepatocellular carcinoma (HCC) with pegylated liposomal doxorubicin (Caelyx). In: (Proceedings) 2003 ASCO Annual Meeting/39th Annual Meeting, Chicago, Illinois.. (pp. 361-). Proceedings of the American Society of Clinical Oncology

David, F; (2003) Birth defects drug is poised for comeback. Financial Times

Davidoff, AM; Ng, CY; Zhou, J; Spence, Y; Nathwani, AC; (2003) Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood , 102 (2) pp. 480-488. 10.1182/blood-2002-09-2889. Green open access
file

Davies, JK; Joh, MB; Prentice, HG; Lowdell, MW; (2003) Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3. In:

Davies, JK; Koh, MB; Verfuerth, S; Mackinnon, S; Lowdell, MW; (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells within the donor cell pool. In: BLOOD. (pp. 965A - 965A). AMER SOC HEMATOLOGY

Davies, JK; Koh, MBC; Verfeurth, S; MACKINNON, S; Lowdell, MW; (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells. In: (pp. 965-).

Davies, JK; Lowdell, MW; (2003) New advances in acute graft-versus-host disease prophylaxis. TRANSFUSION MED , 13 (6) 387 - 397.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. BLOOD , 102 (11) 3542-.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. In: BLOOD. (pp. 951A - 951A). AMER SOC HEMATOLOGY

Davies, JK; Marden, CM; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - implications for development of an allogenic NK cell recipient conditioning approach. In: (pp. 951-).

Davis, AM; Dische, S; Gerber, L; Saunders, M; Leung, SF; O'Sullivan, B; (2003) Measuring postirradiation subcutaneous soft-tissue fibrosis: State-of-the-art and future directions. Seminars in Radiation Oncology , 13 (3) pp. 203-213.

DeCanha, S; Hoskin, PJ; (2003) Current thinking of the role of radiotherapy in metastatic disease. In: Miles, A, (ed.) Key Advances in the effective Management of Breast Cancer. Royal College of Physicians: London.

Dearling, JL; Flynn, AA; Sutcliffe-Goulden, J; Boden, R; Boxer, GM; Begent, RHJ; Pedley, RB; (2003) Deoxyglucose microdistribution in major pathophysiological tumour compartments. In: (pp. 24-).

Dehout, F; Schwarting, A; Beck, M; Mehta, A; Ricci, R; Widmer, UFOSI; (2003) Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatrica - Supplement , 92 (443) pp. 14-15.

Dhar, A; Johnson, KS; Novelli, MR; Bown, SG; Lovat, LB; Bloom, SL; (2003) Optical biopsy of colonic lesions: Comparison of elastic scattering spectroscopy with histology. In: (pp. A1-).

Dische, S; Saunders, MI; (2003) Complexity and simplicity in the measurement and recording of the adverse effects of cancer treatment. Radiotherapy And Oncology , 66 (3) pp. 249-251.

Diss, TC; (2003) The Polymerase Chain Reaction. In: Crocker, J and Murray, PG, (eds.) Molecular Biology in Cellular Pathology. (pp. 193-212). John Wiley and Sons: West Sussex.

Dittrich, C; Dumez, H; Calvert, H; Hanauske, A; Faber, M; Wanders, J; Yule, M; (2003) Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors. CLIN CANCER RES , 9 (14) 5195 - 5204.

Dogan, A; Attygalle, AD; Kyriakou, C; (2003) Angioimmunoblastic T-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 121 (5) pp. 681-691. 10.1046/j.1365-2141.2003.04335.x.

Donev, R; Horton, R; Beck, S; Doneva, T; Vatcheva, R; Bowen, WR; Sheer, D; (2003) Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex. J BIOL CHEM , 278 (7) 5214 - 5226. 10.1074/jbc.M206621200. Gold open access

Douar, AM; Poulard, K; Danos, O; (2003) Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid. Virology , 309 (2) pp. 203-208.

Duarte, RF; Morris, EC; Shaw, BE; Thomson, KJ; Ethell, M; Peggs, KS; Potter, MN; (2003) Recipient CMV seropositivity may adversely affect the outcome of unrelated donor transplantation by increasing the risk of disease relapse. In: BLOOD. (pp. 489A - 489A). AMER SOC HEMATOLOGY

Dudderidge, TJ; (2003) Urinary markers in bladder cancer. BJU INT , 92 (7) 823 - 824.

Dudderidge, TJ; Arya, M; Young, J; Davies, AJW; (2003) Stop those anti-platelet drugs before surgery! BJU Int , 92 (6) pp. 654-655.

Dudderidge, TJ; Arya, M; Young, J; Davies, AJW; (2003) Untitled. BJU INT , 92 (6) 654 - 655.

Duke, VM; Gandini, D; Sherrington, PD; Lin, K; Heelan, B; Amlot, P; Mehta, AB; (2003) V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica , 88 (11) 1259 - 1271. Green open access
file

Dupuis, S; Jouanguy, E; Al-Hajjar, S; Fieschi, C; Al-Mohsen, IZ; Al-Jumaah, S; Yang, K; (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet , 33 (3) pp. 388-391. 10.1038/ng1097.

de Bruin, EC; Meersma, D; de Wilde, J; den Otter, I; Schipper, EM; Medema, JP; Peltenburg, LTC; (2003) A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ , 10 (10) pp. 1204-1212. 10.1038/sj.cdd.4401296.

de Groot, NG; Garcia, CA; Doxiadis, GGM; Marsh, SGE; Bontrop, RE; (2003) The "non-classical" MIC gene in chimpanzees shows reduced exon/intron variation as compared to humans. Genes and Immunity , 4 6-.

E

Eccersley, AJ; Wilson, EM; Makris, A; Novell, JR; (2003) Referral guidelines for colorectal cancer - do they work? Annals of the Royal College of Surgeons of England , 85 (2) pp. 107-110.

Eisman, S; Mehta, A; Orteu, CH; (2003) Case 3. Fabry disease. Clinical and Experimental Dermatology , 28 (5) pp. 569-570.

El Hamidi, A; Kocjan, G; Du, MQ; (2003) Clonality analysis of archival cervical smears - Correlation of monoclonality with grade and clinical behavior of cervical intraepithelial neoplasia. ACTA CYTOL , 47 (2) 117 - 123.

Enver, T; (2003) Blueprints for blood. BLOOD , 101 (2) p. 381. 10.1182/blood-2002-11-3426.

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; Hoffmann, R; (2003) Transcriptional programming and reprogramming in haematopoietic stem cells. In: (Proceedings) 13th Conference on Hemoglobin Switching. (pp. pp. 139-140). ACADEMIC PRESS INC ELSEVIER SCIENCE

F

Fallen, PR; Duarte, RF; McGreavey, L; Potter, M; Ethell, M; Prentice, HG; Madrigal, JA; (2003) Identification of non-naive CD4(+) CD45RA(+) T cell subsets in adult allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPL , 32 (6) 609 - 616. 10.1038/sj.bmt.1704185.

Fallen, PR; Duarte, RF; McGreavey, L; Potter, M; Ethell, M; Prentice, HG; Madrigal, JA; (2003) Identification of non-naive CD4(+) CD45RA(+) T cell subsets in adult allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPLANTATION , 32 (6) pp. 609-616.

Fallen, PR; McGreavey, L; Madrigal, JA; Potter, M; Ethell, M; Prentice, HG; Guimaraes, A; (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPL , 32 (10) 1001 - 1014. 10.1038/sj.bmt.1704235.

Fallen, PR; McGreavey, L; Madrigal, JA; Potter, M; Ethell, M; Prentice, HG; Guimaraes, A; (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPLANTATION , 32 (10) pp. 1001-1014.

Field, N; Low, W; Daniels, M; Howell, S; Daviet, L; Boshoff, C; Collins, M; (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J CELL SCI , 116 (18) 3721 - 3728. 10.1242/jcs.00691.

Fields, PA; Cohen, H; Patterson, KG; (2003) Splenunculectomy in autoimmune thrombocytopenic purpura. Br J Haematol , 123 (3) 377-.

Flanagan, AM; Massey, HM; (2003) Generating human osteoclasts in vitro from bone marrow and peripheral blood. In: UNSPECIFIED (pp. 113-128).

Flanagan, AM; Massey, HM; (2003) Generating human osteoclasts in vitro from bone marrow and peripheral blood. Methods Mol Med , 80 pp. 113-128. 10.1385/1-59259-366-6:113.

Flanagan, J; Healey, S; Young, J; Whitehall, V; Chenevix-Trench, G; (2003) Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumour suppressor gene in colorectal cancer. International Journal of Cancer , 106 (4) pp. 505-509.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Boden, RABRHJ; (2003) The heterogeneity of antibody distribution in kidney and its influence on dosimetry. Radiation Research , 159 pp. 182-189.

Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; Boden, R; (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. RADIAT RES , 159 (2) 182 - 189.

Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; Boden, R; (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. Radiat Res , 159 (2) pp. 182-189.

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehra, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye. In: BLOOD. (pp. 347B - 348B). AMER SOC HEMATOLOGY

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehta, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukemia patients using a highly fluorescent Alexa Fluor dye. In: (pp. 5116-).

Foroni, L; Sorour, AF; Sinclair, PB; Duke, VM; (2003) Loss of heterozygosity (LOH) and microsatellite instability (MSI) of chromosome 6q16-21 identifies a prognostically poor group of childhood and adult T cell precursor acute lymphoblastic leukaemia (ALL) patients. BLOOD , 102 (11) 2236-.

Forshew, T; Johnson, CA; Willis, C; Moore, AT; Maher, ER; (2003) Mapping of an autosomal recessive congenital cataract locus to chromosome 9q. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 489 - 489). UNIV CHICAGO PRESS

Forshew, T; Johnson, CA; Willis, C; Moore, AT; Maher, ER; (2003) Mapping of an autosomal recessive congenital cataract locus to chromosome 9q. In: JOURNAL OF MEDICAL GENETICS. (pp. S86 - S86). B M J PUBLISHING GROUP

Francis, DL; Freeman, A; Visvikis, D; Costa, DC; Luthra, SK; Novelli, M; Taylor, I; (2003) Can PET quantify cellular proliferation in colorectal cancer? A comparative study using MIB-1 and a new PET tracer 18FLT. In: (pp. pp. 29-30).

Francis, DL; Freeman, A; Visvikis, D; Costa, DC; Luthra, SK; Novelli, M; Taylor, I; (2003) In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. Gut , 52 (11) pp. 1602-1606.

Francis, DL; Freeman, A; Visvikis, D; Costa, DC; Luthra, SK; Novelli, M; Taylor, I; (2003) Quantifying cellular proliferation in colorectal cancer: comparison between positron emission tomography and MIB-1 immunohistochemistry. In: BRITISH JOURNAL OF SURGERY. (pp. 78 - 78). JOHN WILEY & SONS LTD

Frattini, A; Pangrazio, A; Susani, L; Sobacchi, C; Mirolo, M; Abinun, M; Andolina, M; (2003) Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. JOURNAL OF BONE AND MINERAL RESEARCH , 18 (10) pp. 1740-1747. 10.1359/jbmr.2003.18.10.1740.

Freeman, MAR; MacInnes, T; Revell, PA; (2003) The histology of "reactive lines"' in well-fixed components. The Journal of Arthroplasty , 18 (2) pp. 224-226.

Fricke, B; Argent, AC; Chetty, MC; Pizzey, AR; Turner, EJ; Ho, MM; Lolascon, A; (2003) The "stomatin" gene and protein in overhydrated hereditary stomatocytosis. BLOOD , 102 (6) 2268 - 2277. 10.1182/blood-2002-06-1705.

Fricke, B; Stewart, GW; Treharne, KJ; Mehta, A; Knopfle, G; Friedrichs, N; Muller, KM; (2003) Stomatin immunoreactivity in ciliated cells of the human airway epithelium. ANAT EMBRYOL , 207 (1) 1 - 7. 10.1007/s00429-003-0324-7.

Friedmann, BJ; Caplin, M; Hartley, JA; Hochhauser, D; (2003) UNSPECIFIED In: (Proceedings) Modulation of the activity of chemotherapeutic agents by the epidermal growth factor inhibitor gefitinib ('Iressa', ZD1839). Clinical Cancer Research

Friedmann, BJ; Caplin, M; Hartley, JA; Hochhauser, D; (2003) Modulation of the activity of chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in human cancer cell lines. In: CLINICAL CANCER RESEARCH. (pp. 6094S - 6094S). AMER ASSOC CANCER RESEARCH

Frleta, D; Lin, JT; Quezada, SA; Wade, TK; Barth, RJ; Noelle, RJ; Wade, WF; (2003) Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice. J IMMUNOTHER , 26 (1) 72 - 84.

G

Gaffan, J; Holden, L; Newlands, ES; Short, D; Fuller, S; Begent, RHJ; Rustin, GJS; (2003) Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. BRIT J CANCER , 89 (10) 1849 - 1854. 10.1038/sj.bjc.6601383.

Gale, RE; (2003) Pathogenic markers in essential thrombocythemia. Curr Hematol Rep , 2 (3) pp. 242-247.

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2003) No mutations in the GATA-1 gene detected in patients with the acquired myeloproliferative disorder essential thrombocythaemia. In: BLOOD. (pp. 662A - 662A). AMER SOC HEMATOLOGY

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; (2003) Ansamycins synergize with conventional drugs in apoptotic killing of B-chronic lymphocytic leukaemia cells. In:

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; (2003) Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. In: BLOOD. (pp. 349B - 349B). AMER SOC HEMATOLOGY

Garcia, CA; Robinson, J; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2003) Human KIR sequences 2003. IMMUNOGENETICS , 55 (4) pp. 227-239. 10.1007/s00251-003-0572-y.

Garcia, CA; Robinson, J; Madrigal, JA; Marsh, SGE; (2003) Natural killer cell receptors: Functional roles. Inmunologia , 22 (2) pp. 190-202.

Gardiner, C; Pennaneac'h, C; Mackie, IJ; Sheldrake, A; Harrison, J; Machin, SJ; (2003) Falsely elevated D-dimer results in a healthy patient on account of heterophiletul antibodies. BRIT J HAEMATOL , 122 (5) 871 - 873.

Geddes, JF; Tasker, RC; Hackshaw, AK; Nickols, CD; Adams, GGW; Whitwell, HL; Scheimberg, I; (2003) Dural haemorrhage in non-traumatic infant deaths: does it explain the bleeding in 'shaken baby syndrome'? NEUROPATH APPL NEURO , 29 (1) 14 - 22.

Gerrard, G; Ganeshaguru, G; Payne, B; Baker, R; McCullough, H; Jones, DT; Potter, M; (2003) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride. In: (Proceedings) 5th International Symposium on Leukemia and Lymphoma. (pp. p. 665). NATURE PUBLISHING GROUP

Ginhoux, F; Doucet, C; Leboeuf, M; Lemonnier, FA; Danos, O; Davoust, J; Firat, H; (2003) Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy. Mol Ther , 8 (2) pp. 274-283.

Glassford, J; Soeiro, I; Koyasu, S; Lam, EWEA; (2003) BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene , 22 (15) pp. 2248-2259.

Godfrey, A; Laman, H; Boshoff, C; (2003) RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus. CURR OPIN INFECT DIS , 16 (6) 593 - 600. 10.1097/01.qco.0000104301.87920.4a.

Grandage, VL; Linch, DC; Khwaja, A; (2003) P13Kinase is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NFkB, MAPKinase and P53 pathways. In: BLOOD. (pp. 585A - 585A). AMER SOC HEMATOLOGY

Gribble, SM; Reid, AG; Bench, AJ; Huntly, BJP; Grace, C; Green, AR; Nacheva, EP; (2003) Molecular cytogenetics of polycythaemia vera: lack of occult rearrangements detectable by 20q LSP screening, CGH, and M-FISH. In: LEUKEMIA. (pp. 1419 - 1421). NATURE PUBLISHING GROUP

Gribble, SM; Reid, AG; Roberts, I; Grace, C; Green, AR; Nacheva, EP; (2003) Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over- representation. GENE CHROMOSOME CANC , 37 (4) 346 - 358.

Grigg, A; Solal-Celigny, P; Hoskin, P; Taylor, K; McMillan, A; Forstpointner, R; Bacon, P; (2003) Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma. Leukemia and Lymphoma , 44 (9) pp. 1503-1508.

Grimshaw, GM; Szczepura, A; Hultén, M; MacDonald, F; Nevin, NC; Sutton, F; Dhanjal, S; (2003) Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess , 7 (10) pp. 1-146.

Gross, D-A; Leboeuf, M; Gjata, B; Danos, O; Davoust, J; (2003) CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood , 102 (13) pp. 4326-4328. 10.1182/blood-2003-05-1454.

Grote, D; Cattaneo, R; Fielding, AK; (2003) Neutrophils contribute to the measles virus-induced antitumor effect: Enhancement by granulocyte macrophage colony-stimulating factor expression. CANCER RES , 63 (19) 6463 - 6468.

H

Hackshaw, A; (2003) Paper does not diminish conclusion of previous reports. On behalf of the International Agency for Research on Cancer Working Group on Smoking and Involuntary smoking. BMJ (Clinical Research Ed.) , 327 pp. 501-502.

Hackshaw, AK; (2003) The EUSOMA review on mammography screening. In: Proceedings from the Global Summit on Mammographic Screening, Milan 2002. Annals of Oncology , 14 pp. 1193-1195.

Hackshaw, AK; Paul, EA; (2003) Breast self-examination and death from breast cancer: a meta-analysis. BRIT J CANCER , 88 (7) 1047 - 1053. 10.1038/sj.bjc.6600847.

Hadjur, S; Jirik, FR; (2003) Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. BLOOD , 101 (10) 3877 - 3884.

Hague, A; Eveson, JW; Huntley, S; Janghra, N; Thavaraj, S; (2003) Caspase-3 expression is increased in lip and oral squamous cell carcinomas and positively correlates with more advanced tumour stage. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 36A-36A). JOHN WILEY & SONS LTD

Hajioff, D; Enever, Y; Quiney, R; Zuckerman, JN; MacDermot, K; Mehta, A; (2003) Hearing loss in Fabry Disease: the effect of agalsidase alfa replacement therapy. Journal of Inherited Metabolic Disease , 26 (8) pp. 787-794.

Hajioff, D; Goodwin, S; Quiney, R; Zuckerman, JN; MacDermot, KD; Mehta, A; (2003) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatrica , 92 (443) pp. 28-30.

Hamidi, AEL; Kocjan, G; Du, MQ; (2003) Clonality analysis of archival cervical smear: monocloniality correlates with grade and clinical behaviour of CIN. Acta Cytologica , 47 pp. 117-123.

Hammond, KL; Loynes, HE; Folarin, AA; Smith, J; Whitfield, TT; (2003) Hedgehog signalling is required for correct anteroposterior patterning of the zebrafish otic vesicle. DEVELOPMENT , 130 (7) 1403 - 1417. 10.1242/dev.00360.

Harney, J; Goodchild, K; Phillips, H; Glynne-Jones, R; Hoskin, PJ; Saunders, MI; (2003) A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. Clinical Oncology , 15 (3) pp. 109-114.

Harney, J; Shah, N; Short, S; Saunders, M; Joiner, M; (2003) Low dose hyper-radiosensitivity-a clinical assessment. In: (pp. Abs 173-).

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: Interpretation of fluorescence in situ hybridization results. British Journal of Haematology , 120 (6) pp. 944-952. 10.1046/j.1365-2141.2003.04172.x.

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. BRIT J HAEMATOL , 120 (6) 944 - 952.

Hart, DP; Avivi, I; Thomson, KJ; Goldstone, AH; Linch, DC; Ell, PJ; Bomanji, JB; (2003) Use of Positron Emission Tomography following reduced intensity allograft for Hodgkin and Non Hodgkin Lymphoma to guide Donor Lymphocyte Infusion administration. In: BLOOD. (pp. 725A - 726A). AMER SOC HEMATOLOGY

Hart, DP; Thomson, KJ; Bannerjee, L; Morris, EC; Linch, DC; Goldstone, AH; Peggs, KS; (2003) Very low dose aciclovir prophylaxis post allogeneic stem cell transplantation prevents varicella zoster infection without development of clinically relevant resistance. In: BLOOD. (pp. 971A - 971A). AMER SOC HEMATOLOGY

Hergovich, A; Lisztwan, J; Barry, R; Ballschmieter, P; Krek, W; (2003) Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. NAT CELL BIOL , 5 (1) 64 - 70. 10.1038/ncb899.

Herrero, J; Al-Shahrour, F; Diaz-Uriarte, R; Mateos, A; Vaquerizas, JM; Santoyo, J; Dopazo, J; (2003) GEPAS: a web-based resource for microarray gene expression data analysis. NUCLEIC ACIDS RESEARCH , 31 (13) pp. 3461-3467. 10.1093/nar/gkg591.

Herrero, J; Diaz-Uriarte, R; Dopazo, J; (2003) An approach to inferring transcriptional regulation among genes from large-scale expression data. COMPARATIVE AND FUNCTIONAL GENOMICS , 4 (1) pp. 148-154. 10.1002/cfg.237. Gold open access

Herrero, J; Díaz-Uriarte, R; Dopazo, J; (2003) Gene expression data preprocessing. Bioinformatics , 19 (5) pp. 655-656.

Hewison, M; Freeman, L; Hughes, SV; Evans, KN; Bland, R; Eliopoulos, AG; Kilby, MD; (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J IMMUNOL , 170 (11) 5382 - 5390.

Horton, MA; Massey, HM; Flanagan, AM; (2003) Upregulation of à2á1 Integrin in á3 null type Glanzmann thrombasthenia enables bone resorption. British Journal of Haematology , 122 pp. 950-957.

Horton, MA; Massey, HM; Rosenberg, N; Nicholls, B; Seligsohn, U; Flanagan, AM; (2003) Upregulation of osteoclast alpha 2 beta 1 integrin compensates for lack of alpha v beta 3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. BRIT J HAEMATOL , 122 (6) 950 - 957.

Horton, R; Beck, S; (2003) Accessing HLA sequencing data through the 6ace database. Methods Mol Biol , 210 pp. 23-42.

Hoskin, PJ; (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treatment Reviews , 29 (4) pp. 321-327.

Hoskin, PJ; (2003) Case selection in the management of cerebral metastases. Clinical Oncology , 15 (7) pp. 420-421.

Hoskin, PJ; (2003) What are the oncologist's need. European Journal of Nuclear Medicine and Molecular Imaging , 30 (S1) S37-S41. 10.1007/s00259-003-1158-5.

Hoskin, PJ; (2003) Radiotherapy in symptom management. In: Doyle, D and Hanks, GW and Cherny, N and Calman, K, (eds.) Oxford Textbook of Palliative Care. Oxford University Press.: Oxford.

Hoskin, PJ; (2003) Evaluation and management of the patient with bone metastases at presentation. In: Jasmin, C and Caanna, R and Coia, L and Coleman, R and Diel, I, (eds.) Textbook of Bone Metastases. Wiley: Chichester.

Hoskin, PJ; Bownes, PJ; Ostler, P; Walker, K; Bryant, L; (2003) High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiotherapy And Oncology , 68 (3) pp. 285-288.

Hoskin, PJ; Grover, A; Bhana, R; (2003) Metastatic spinal cord compression: radiotherapy outcome and dose fractionation. Radiotherapy And Oncology , 68 (2) pp. 175-180.

Hoskin, PJ; O'Doherty, MJ; (2003) Lymphoma: Diagnosis and Management. European Journal Of Nuclear Medicine and Molecular Imaging , 30 (S1) BP87-BP98. 10.1007/s00259-003-1342-7.

Hoskin, PJ; Sibtain, A; Daley, FM; Wilson, GD; (2003) GLUTI and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. British Journal of Cancer , 89 (7) pp. 1290-1297. 10.1038/sj.bjc.6601260.

Howie, AJ; Turhan, N; Adu, D; (2003) Powerful morphometric indicator of prognosis in lupus nephritis. QJM , 96 (6) pp. 411-420. 10.1097/01.TP.0000120177.44144.FF.

Hughes, SE; (2003) Detection of apoptosis by in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon. The Journal of Pathology (201) pp. 181-186.

Huhalov, A; Spencer, DI; Chester, KA; (2003) Mapping Antibody:Antigen Interactions by Mass Spectrometry and Bioinformatics. In: Lo, BKC, (ed.) Antibody Engineering Methods and Protocols. (pp. 465-480). Humana Press

Hulten, MA; Dhanjal, S; Pertl, B; (2003) Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. REPRODUCTION , 126 (3) 279 - 297.

Hunter, HM; Peggs, K; Powles, R; Apperley, J; Mahendra, P; Cavenagh, J; Littlewood, T; (2003) A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma. In: (pp. 2705-).

Hunter, HM; Peggs, K; Powles, R; Apperley, J; Mahendra, P; Cavenagh, J; Littlewood, T; (2003) A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma. In: BLOOD. (pp. 732A - 732A). AMER SOC HEMATOLOGY

Huntly, BJP; Guilhot, F; Reid, AG; Vassiliou, G; Hennig, E; Franke, C; Byrne, J; (2003) Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. In: BLOOD. (pp. 2205 - 2212). AMER SOC HEMATOLOGY

I

Irwin, HL; Corcoran, F; Boxer, GM; Pedley, RB; Dearling, J; Hartley, JM; Begent, RHJ; (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). British Journal of Cancer , 88 S37-S37.

Irwin, HL; Corcoran, F; Boxer, GM; Pedley, RB; Dearling, J; Hartley, JM; Begent, RHJ; (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). In: BRITISH JOURNAL OF CANCER. (pp. S37 - S37). NATURE PUBLISHING GROUP

J

Jacqui, T; (2003) Thalidomide used to fight lung cancer. ‘Deformity’ drug in new trial. The Sun 16-.

James, L; Lee, SM; (2003) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) 10th World Conference on Lung Cancer, Vancouver.. (pp. S183-). Lung Cancer

James, M; (2003) Lung cancer curbed in thalidomide trial. The Guardian

Janinis, J; Patriki, M; Vini, L; Aravantinos, G; Whelan, JS; (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Annals of Oncology , 14 pp. 181-190.

Jarvis, M; Marzolini, M; Wang, XN; Jackson, G; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. Transplantation , 76 (5) pp. 849-853. 10.1097/01.TP.0000083556.73555.78.

Jarvis, M; Marzolini, MAV; Wang, XN; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: Correlation of expression with degree of graft-versus-host response and clinical GVHD: Quantitative assessment using laser scanning confocal microscopy. In: (pp. S47-S47). Nature Publishing Group

Jenner, RG; Maillard, K; Cattini, N; Weiss, RA; Boshoff, C; Wooster, R; Kellam, P; (2003) Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile. P NATL ACAD SCI USA , 100 (18) 10399 - 10404. 10.1073/pnas.1630810100.

John, G; (2003) Thalidomide. An unlikely cure? Guardian 60-.

John, T; Ottley, C; Pearson, G; Nowell, G; Calvert, H; Tilby, M; (2003) Sensitive determination of BBR 3464 and cisplatin DNA adduct levels in clinical samples using ICP-MS and PIMMS. In: BRITISH JOURNAL OF CANCER. (pp. S42 - S42). NATURE PUBLISHING GROUP

John, T; Ottley, CJ; Pearson, DG; Nowell, GM; Calvert, H; Tilby, MJ; (2003) Determination, by ICP-MS, of background and BBR 3464 induced levels of platinum bound to DNA isolated from blood cells: A comparison of the sensitivity of the Perkin Elmer Sciex Elan 6000 and the thermofinnigan Neptune instruments. In: Holland, JG and Tanner, SD, (eds.) PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES. (pp. 82 - 90). ROYAL SOC CHEMISTRY

Jones, C; Mackay, A; Grigoriadis, A; Cossu, A; Reis, JS; Fulford, LG; Dexter, T; (2003) Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S12 - S12). KLUWER ACADEMIC PUBL

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. BLOOD , 101 (8) 3174 - 3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood , 101 (8) pp. 3174-3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. BRIT J HAEMATOL , 121 (5) 713 - 720.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol , 121 (5) pp. 713-720.

Joshi, C; Enver, T; (2003) Molecular complexities of stem cells. CURRENT OPINION IN HEMATOLOGY , 10 (3) pp. 220-228. 10.1097/00062752-200305000-00005.

K

Kalra, D; Singleton, P; Ingram, D; Milan, J; Mackay, J; Detmer, D; Rector, A; (2003) Security and confidentiality approach for the Clinical E-Science Framework (CLEF). In: Cox, S, (ed.) Proceedings of UK e-Science All Hands Meeting 2003. (pp. 825-832). Engineering and Physical Sciences Research Council (EPSRC)

Karzynski, M; Mateos, A; Herrero, J; Dopazo, J; (2003) Using a genetic algorithm and a perceptron for feature selection and supervised class learning in DNA microarray data. Artificial Intelligence Review , 20 (1-2) pp. 39-51. 10.1023/A:1026032530166.

Kate, N; (2003) Bag Drug Makes Good. TIME Magazine 59-.

Kauppila, S; Maaty, WSA; Chen, P; Tomar, RS; Eby, MT; Chapo, J; Chew, S; (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene , 22 (31) pp. 4860-4867. 10.1038/sj.onc.1206715.

Kellam, P; Holzerlandt, R; Gramoustianou, E; Jenner, R; Kwan, A; (2003) Viral bioinformatics: computational views of host and pathogen. Novartis Found Symp , 254 pp. 234-247.

Kerr, D; McArdle, C; Ledermann, J; Taylor, I; (2003) Hepatic artery chemotherapy and colorectal liver metastases - Reply. The Lancet , 361 (9370) p. 1743.

Kerr, D; McArdle, C; Ledermann, J; Taylor, I; (2003) Hepatic artery chemotherapy and colorectal liver metastases - Reply. LANCET , 361 (9370) 1743 - 1743.

Kerr, DJ; McArdle, CS; Ledermann, J; Taylor, I; Sherlock, DJ; Schlag, PM; Buckels, J; (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. LANCET , 361 (9355) 368 - 373.

Keshtgar, MR; Stein, RC; (2003) Breast cancer. [Book]. Patient's pictures. (1st ed.). Health Press Limited: Oxford.

Khalil, AA; Bentzen, SM; Bernier, J; Saunders, MI; Horiot, JC; Van Den Bogaert, W; Cummings, BJ; (2003) Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. International Journal of Radiation Oncology Biology Physics , 55 (3) pp. 568-575.

Khan, K; Kostoula, V; Savage, K; Stubbs, M; McStay, M; Dhillon, AP; Caplin, ME; (2003) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? In: (pp. 333-).

Khan, K; Kostoula, V; Savage, K; Stubbs, M; McStay, M; Dhillon, AP; Caplin, ME; (2003) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? In: GUT. (pp. A91 - A91). BRITISH MED JOURNAL PUBL GROUP

Kibe, T; Tomita, K; Matsuura, A; Izawa, D; Kodaira, T; Ushimaru, T; Uritani, M; (2003) Fission yeast Rhp51 is required for the maintenance of telomere structure in the absence of the Ku heterodimer. Nucleic Acids Res , 31 (17) pp. 5054-5063. Gold open access

Kichler, A; Leborgne, C; März, J; Danos, O; Bechinger, B; (2003) Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci U S A , 100 (4) pp. 1564-1568. 10.1073/pnas.0337677100.

Kichler, A; Sabourault, N; Décor, R; Leborgne, C; Schmutz, M; Valleix, A; Danos, O; (2003) Preparation and evaluation of a new class of gene transfer reagents: poly(-alkylaminosiloxanes). J Control Release , 93 (3) pp. 403-414.

Kocjan, G; (2003) Fine needle aspiration cytology - Inadequate rates compromise success. CYTOPATHOLOGY , 14 (6) 307 - 308.

Kocjan, G; (2003) Fine needle aspiration cytology. Cytopathology , 14 (6) pp. 307-308.

Kostoula, V; Khan, K; Savage, K; Hochhauser, D; Stubbs, M; McStay, M; Dhillon, AP; (2003) Expression of c-kit (cd117) in neuroendocrine tumours - a target for therapy? ENDOCR-RELAT CANCER , 10 (4) 508 - 508.

Kotecha, MT; Hercus, L; Lees, SM; Hartley, JA; Hochhauser, D; (2003) Modulation of topoisomerase Iia expression by sequence specific polyamides. In: (pp. 6539-).

Kottaridis, PD; Gale, RE; Linch, DC; (2003) FLT3 mutations and leukaemia. BRIT J HAEMATOL , 122 (4) 523 - 538.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) Flt3 mutations and leukaemia. British Journal of Haematology , 122 (4) pp. 523-538.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. LEUKEMIA LYMPHOMA , 44 (6) 905 - 913. 10.1080/1024819031000067503.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. Leukemia and Lymphoma , 44 (6) pp. 905-913.

Krause, M; Hessel, F; Wohlfarth, J; Zips, D; Hoinkis, C; Foest, H; Short, S; (2003) Ultrafractionation in A7 malignant glioma in nude mice. pp. 377-383.

Krishnan, B; Ganeshaguru, K; Baker, R; Richfield, L; Mehta, AB; (2003) Multidrug resistance and myelomonocytic leukaemia in gaucher's disease. Haematologica , 88 (2) ECR02-. Green open access
file

Kristeleit, RS; Stimson, L; Workman, P; Aherne, GW; (2003) Effects of the hydroxamic acid histone deacetylase inhibitors trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA) and LAQ824 on histone and protein acetylation. In: CLINICAL CANCER RESEARCH. (pp. 6107S - 6107S). AMER ASSOC CANCER RESEARCH

Kroger, N; Thomson, K; Zabelina, T; Peggs, K; Chopra, R; Shimoni, A; Nagler, A; (2003) Comparison between anti-thymocyte globulin and alemtuzumab in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies. In: BLOOD. (pp. 484A - 484A). AMER SOC HEMATOLOGY

Kyriacou, C; KOTTARIDIS, PD; Eliahoo, J; MACKINNON, S; (2003) Germ cell damage adn Leydig cell insufficiency in recipients of non-myeloablative transplantation for haematological malignancies. Bone Marrow Transplantation , 31 pp. 45-50.

Kyriacou, C; Kottaridis, PD; Eliahoo, J; McKeag, N; Bomford, J; McGarrigle, HH; Linch, DC; (2003) Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. Bone Marrow Transplantation , 31 (1) pp. 45-50.

Kyriacou, C; Kottaridis, PD; Eliahoo, J; Mckeag, N; Bomford, J; McGarrigle, HH; Linch, DC; (2003) Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. BONE MARROW TRANSPL , 31 (1) 45 - 50. 10.1038/sj.bmt.1703777.

Kyriakou, CA; D'Sa, SP; Flory, A; Hanslip, J; Peggs, KS; Yong, KL; (2003) Cyclophosphamide, dexamethasone and thalidomide (CDT) is a well tolerated and effective regimen in advanced relapsed/refractory myeloma. In: (pp. 5270-).

Kyriakou, CA; D'Sa, SP; Flory, A; Hanslip, J; Peggs, KS; Yong, KL; (2003) Cyclophosphamide, dexamethasone and thalidomide (CDT) is a well tolerated and effective regimen in advanced relapsed/refractory myeloma. In: BLOOD. (pp. 386B - 386B). AMER SOC HEMATOLOGY

Kyriakou, CA; Tsang, L; Pizzey, A; Hanawa, H; Yong, K; Nathwani, AC; (2003) Critical evaluation of the parameters that influence efficient transduction of human bone marrow derived mesenchymal stem cells with highly atenuated HIV based SIN lentiviral vectors pseudotyped with a variety of envelope proteins. In: (Proceedings) 6th Annual Meeting of the American-Society-of-Gene-Therapy. (pp. S334-S335). NATURE PUBLISHING GROUP

Kyriakou, CA; Yong, KL; Benjamin, R; Gandini, D; Davidoff, AM; Nathwani, AC; (2003) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral mediated gene transfer inhibit growth of Burkitt's lymphoma in murine models. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

L

Lacombe, D; Butler-Smith, A; Therasse, P; Fumoleau, P; Burtles, S; Calvert, H; Marsoni, S; (2003) Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network. CANCER INVEST , 21 (1) 137 - 147. 10.1081/CNV-120016408.

Laderach, D; Compagno, D; Danos, O; Vainchenker, W; Galy, A; (2003) RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol , 171 (4) pp. 1750-1757.

Lambert, S; Mason, SJ; Barber, LJ; Hartley, JA; Pearce, JA; Carr, AM; McHugh, PJ; (2003) Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. MOL CELL BIOL , 23 (13) 4728 - 4737.

Lawrie, AS; Gray, E; Leeming, D; Davidson, SJ; Purdy, G; Iampietro, R; Craig, S; (2003) A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique. BRIT J HAEMATOL , 123 (2) 335 - 341.

Lea, NC; Orr, SJ; Stoeber, K; Williams, GH; Lam, EWF; Ibrahim, MAA; Mufti, GJ; (2003) Commitment point during G(0)-> G(1) that controls entry into the cell cycle. MOL CELL BIOL , 23 (7) 2351 - 2361. 10.1128/MCB.23.7.2351-2361.2003.

Ledermann, JA; Colombo, N; du Bois, A; Torri, V; Floriani, I; Qian, W; Adams, HP; (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003). LANCET , 362 (9394) 1504 - 1504.

Ledermann, JA; ICON Collaborators, ; AGO Collaborators, ; (2003) Randomised trial of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer (ICON4/OVAR 2.2). BRITISH JOURNAL OF CANCER , 88 S9 - S9.

Lee, AC; Chicken, DW; Pickard, CDO; Briggs, GM; Kocjan, G; Falzon, M; Bigio, I; (2003) Comparative study of elastic scattering spectroscopy and touch imprint cytology in assessing sentinel lymph node status in breast cancer. In: BRITISH JOURNAL OF SURGERY. (pp. 112 - 112). JOHN WILEY & SONS LTD

Lee, AC; Pickard, CDO; Briggs, GM; Sainsbury, JR; Falzon, M; Kocjan, G; Bigio, I; (2003) Intra-operative assessment by optical biopsy for sentinel lymph node metastasis in breast cancer: update and comparison with imprint cytology. BRITISH JOURNAL OF SURGERY , 90 (5) 625 - 626.

Lee, M; Wilson, D; Lacy, E; Grandillo, J; Le, M; Kiakos, K; Hartley, J; (2003) Microcalorimetry and DNase I footprinting studies on the molecular recognition of T/G mismatched base pairs by stacked polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U199 - U200). AMER CHEMICAL SOC

Lee, SS; Janghra, N; Hague, A; (2003) BAG-1L enhances 1 alpha,25-dihydoxyvitamin D-3-induced growth inhibition in oral keratinocytes by potentiation of vitamin D receptor transactivation. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 29A-29A). JOHN WILEY & SONS LTD

Lee, YC; Flora, R; McCafferty, JA; Gor, J; Tsaneva, IR; Perkins, SJ; (2003) A tetramer-octamer equilibrium in Mycobacterium leprae and Escherichia coli RuvA by analytical ultracentrifugation. J MOL BIOL , 333 (4) 677 - 682. 10.1016/j.jmb.2003.08.047.

Leonard, P; Sharp, T; Henderson, S; Hewitt, D; Pringle, J; Sandison, A; Goodship, A; (2003) Gene expression array profile of human osteosarcoma. BRIT J CANCER , 89 (12) 2284 - 2288. 10.1038/sj.bjc.6601389.

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I phosphoinositide 3-kinase p110 beta is required for apoptotic cell and Fc gamma receptor-mediated phagocytosis by macrophages. JOURNAL OF BIOLOGICAL CHEMISTRY , 278 (40) pp. 38437-38442. 10.1074/jbc.M306649200. Gold open access

Lewis, I; Nooij, M; Whelan, J; Casak, S; Memon, M; Taminiau, A; Hogendoorn, P; (2003) Chemotherapy at standard or increased dose intensity in patients with operable osteosarcoma of the extremity: A randomised controlled trial of the European Osteosarcoma Intergroup (ISRCTN 86294690). In:

Lipton, L; Halford, SE; Johnson, V; Novelli, MR; Jones, A; Cummings, C; Barclay, E; (2003) Carcinogenesis in MYH-Associated Polyposis Follows a Distinct Genetic Pathway. Cancer Research , 63 (22) pp. 7595-7599.

LoRusso, PM; Herbst, RS; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, D; (2003) Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. CLIN CANCER RES , 9 (6) 2040 - 2048.

Love, EM; Jones, H; Williamson, LM; Cohen, H; (2003) SHOT – a voluntary system for the reporting of serious hazards of transfusion in the UK. Transfusion and transfusion alternatives , 5 pp. 248-255.

Lowdell, MW; (2003) Natural killer cells in haematopoietic stem cell transplantation. TRANSFUSION MED , 13 (6) 399 - 404.

Lowdell, MW; (2003) "Out damned spot": ex vivo purging revisited. BLOOD , 102 (12) 3860 - 3861.

Lu, X; (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nature Genetics , 33 pp. 162-167.

Luong, QT; Hills, RK; Drayson, MT; Wheatley, K; Burnett, AK; Linch, DC; Bunce, CM; (2003) Expression of Nm23-H1 in AML correlates with white cell count at diagnosis and in vitro acts as a survival factor for primary AMLs cells; Evidence of a novel autocrine survival factor in AML. BLOOD , 102 (11) 2255-.

Luong, QT; Hills, RK; Drayson, MT; Wheatley, K; Burnett, AK; Linch, DC; Bunce, CM; (2003) Expression of Nm23-H1 in AML correlates with white cell count at diagnosis and in vitro acts as a survival factor for primary AMLs cells; Evidence of a novel autocrine survival factor in AML. In: BLOOD. (pp. 611A - 611A). AMER SOC HEMATOLOGY

Lyn, BE; Wilson, EM; Williams, FJ; Saunders, MI; Phillips, H; (2003) Chart to Chartwel to Chemotherapy and Chartwel in Non-Small Cell Lung Cancer. British Journal of Cancer , 88 S23-S23.

M

MacDonald, D; Henderson, S; Boustead, GB; Boshoff, C; (2003) A pilot study of gene expression analysis of recurrence in superficial bladder cancer. European Urology Supplements , 2 (1) p. 219.

Machin, SJ; (2003) Pros and cons of thrombophilia testing: cons. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 1 (3) pp. 412-413. 10.1046/j.1538-7836.2003.00168.x.

Mackay, HJ; O'Brien, M; Hill, S; Lee, SM; Thatcher, N; Smith, IE; Dunlop, DJ; (2003) A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer. Clinical Oncology , 15 (4) pp. 181-185.

Mackie, IJ; Kitchen, S; Machin, SJ; Lowe, GDO; Brit Comm Stand Haematology, ; (2003) Guidelines on fibrinogen assays. BRIT J HAEMATOL , 121 (3) 396 - 404.

Macropoulos, P; Sieben, N; Kolkman-Uljee, SM; Al Adani, M; Roemen, MJM; de Goeij, APM; Fleuren, J; (2003) RAF/RAS mutations in ovarian neoplasms. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 11A-11A). WILEY-BLACKWELL

Madrigal, JA; Garcia, CA; Gutierrez, ME; Shaw, BE; Arguello, A; Jr, L; A M, M; (2003) El complejo mayor de histocompatibilidad y su papel biologico. HLA y su papel en la evolucion clinica de transplantes y enfermedades autoinmunes. In: Garcia-Conde, JJ and San Migual, JF and Sierra, J and Urbano-Ispizua, A and Vicente, V and Vives Corrons, JL, (eds.) Hematologia. (pp. 105-112). Aran Edcines: Madrid.

Madrigal, JA; Garcia, CA; Gutierrez, ME; Shaw, BE; Arguello, A; Little, AM; March, SGE; (2003) El complejo mayor de histocompatibilidad y su papel biologico. HLA y su papel en la evolucion clinica de transplantes y enfermedades autoinmunes. In: Garcia-Conde, JJ and San Migual, JF and Sierra, J and Urbano-Ispizua, A and Vicente, V and Vives Corrons, JL, (eds.) Hematologia. (pp. 105-112). Aran Edcines: Madrid.

Maffucci, T; Brancaccio, A; Piccolo, E; Stein, RC; Falasca, M; (2003) Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO JOURNAL , 22 (16) pp. 4178-4189. 10.1093/emboj/cdg402.

Maiers, M; Schreuder, GMT; Lau, M; Marsh, SGE; Fernandez-Vina, M; Noreen, H; Setterholm, M; (2003) Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products. TISSUE ANTIGENS , 62 (1) pp. 21-47. 10.1034/j.1399-0039.2003.00097.x.

Makris, A; (2003) Critical commentary of: Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin and flourouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer:an EORTC-NCIC-SAKK multicenter study. Women's Oncology Review , 3 pp. 237-238.

Marafioti, T; Ascani, S; Pulford, K; Sabattini, E; Piccioli, M; Jones, M; Zinzani, PL; (2003) Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol , 162 (3) pp. 861-871. 10.1016/S0002-9440(10)63882-5.

Marafioti, T; Jabri, L; Pulford, K; Brousset, P; Mason, DY; Delsol, G; (2003) Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease. Br J Haematol , 120 (4) pp. 671-678.

Marafioti, T; Jones, M; Facchetti, F; Diss, T; Du, MQ; Issacson, PG; Pozzobon, M; (2003) Interfollicular large B-cells: a subpopulation that may give rise to human lymphomas. BLOOD , 102 pp. 2868-2876.

Marafioti, T; Jones, M; Facchetti, F; Diss, TC; Du, M-Q; Isaacson, PG; Pozzobon, M; (2003) Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood , 102 (8) pp. 2868-2876. 10.1182/blood-2003-03-0692.

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. Blood , 102 (11) 964-.

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: (pp. 964-).

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. BLOOD , 102 (11) 3591-.

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: BLOOD. (pp. 964A - 964A). AMER SOC HEMATOLOGY

Marinovich, M; Binaglia, M; Viviani, B; Bartesaghi, S; Galli, CL; (2003) The dithiocarbamate propineb depolymerizes actin and increases acetylcholine release in differentiated PC12 cells. In: TOXICOLOGICAL SCIENCES. (pp. 267 - 268). OXFORD UNIV PRESS

Marks, AJ; Cooper, M; Orchard, K; Folarin, NI; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; (2003) Targeted therapy with an amphipathic peptide results in selective apoptotic cell death in CD19 positive chronic lymphocytic leukemia cells. BLOOD , 102 (11) 247-.

Marks, AJ; Cooper, M; Orchard, K; Folarin, NI; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; (2003) Targeted therapy with an amphipathic peptide results in selective apoptotic cell death in CD19 positive chronic lymphocytic leukemia cells. In: BLOOD. (pp. 73A - 74A). AMER SOC HEMATOLOGY

Marsh, SGE; (2003) HLA nomenclature and the IMGT/HLA sequence database. In: UNSPECIFIED (pp. 165-173).

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update June 2003. Hum Immunol , 64 (9) pp. 919-920.

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update May 2003. Hum Immunol , 64 (9) pp. 917-918.

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update September 2003. Eur J Immunogenet , 30 (6) 437-.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Hum Immunol , 64 (6) pp. 656-657.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Hum Immunol , 64 (6) 655-.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2002. Hum Immunol , 64 (1) pp. 180-181.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2002. Hum Immunol , 64 (1) 179-.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. JOURNAL OF IMMUNOLOGICAL METHODS , 281 (1-2) pp. 1-8. 10.1016/j.jim.2003.08.001.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 30 (3) pp. 229-234. 10.1046/j.1365-2370.2003.00383.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. IMMUNOGENETICS , 55 (4) pp. 220-226. 10.1007/s00251-003-0571-z.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. TISSUE ANTIGENS , 62 (1) pp. 79-86. 10.1034/j.1399-0039.2003.00072.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. HUMAN IMMUNOLOGY , 64 (6) pp. 648-654. 10.1016/S1098-8859(03)00067-3.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol , 64 (6) pp. 648-654.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Eur J Immunogenet , 30 (3) 237-.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Eur J Immunogenet , 30 (3) 235-.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Eur J Immunogenet , 30 (3) 239-.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Tissue Antigens , 62 (1) pp. 89-90.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Tissue Antigens , 62 (1) pp. 87-88.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Tissue Antigens , 62 (1) pp. 91-92.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Eur J Immunogenet , 30 (4) pp. 299-300.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Tissue Antigens , 62 (4) pp. 333-334.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update August 2002. Eur J Immunogenet , 30 (1) 91-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Tissue Antigens , 61 (5) pp. 412-413.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Eur J Immunogenet , 30 (2) 167-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update July 2002. Eur J Immunogenet , 30 (1) 89-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Eur J Immunogenet , 30 (4) pp. 303-304.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Tissue Antigens , 62 (4) pp. 337-338.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Tissue Antigens , 62 (4) pp. 335-336.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Eur J Immunogenet , 30 (4) 301-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Eur J Immunogenet , 30 (2) pp. 165-166.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Tissue Antigens , 61 (5) pp. 410-411.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Eur J Immunogenet , 30 (1) 95-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Tissue Antigens , 61 (5) pp. 408-409.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update September 2002. Eur J Immunogenet , 30 (1) pp. 93-94.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, April 2003. Hum Immunol , 64 (8) pp. 835-836.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, September 2002. Hum Immunol , 64 (5) pp. 572-573.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2003. Hum Immunol , 64 (12) 1197-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2003. Hum Immunol , 64 (12) pp. 1195-1196.

Martin, F; Chowdhury, S; Neil, SJ; Chester, KA; Cosset, FL; Collins, MK; (2003) Targeted retroviral infection of tumor cells by receptor cooperation. J VIROL , 77 (4) 2753 - 2756. 10.1128/JVI.77.4.2753-2756.2003.

Martin, M; Spielmann, M; Namer, M; duBois, A; Unger, C; Dodwell, D; Vodvarka, P; (2003) Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines. ANN ONCOL , 14 (8) 1246 - 1252. 10.1093/annonc/mdg339.

Martin, MJ; Herrero, J; Mateos, A; Dopazo, J; (2003) Comparing bacterial genomes through conservation profiles. Genome Res , 13 (5) pp. 991-998. 10.1101/gr.678303.

Martino, R; Giralt, S; Caballero, MD; Mackinnon, S; Corradini, P; Fernandez-Aviles, F; San Miguel, J; (2003) Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. HAEMATOLOGICA , 88 (5) 555 - 560. Gold open access

Mason, C; Markusen, JF; Boshoff, CH; (2003) Methods employing cells derived from adult bone marrow.

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; Seymour, MT; Topham, C; McArdle, C; (2003) Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. LANCET , 361 (9356) 457 - 464.

Mayer, A; Tsiompanou, E; Flynn, AA; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. CANCER INVEST , 21 (3) 382 - 388. 10.1081/CNV-120018229.

Mayer, A.; Tsiompanou, E.; Flynn, A.A; Pedley, R.B.; Dearling, J.; Boden, R.; Begent, R.H.J.; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. Cancer Investigation , 21 (3) pp. 382-388. 10.1081/CNV-120018229.

Mburu, P; Mustapha, M; Varela, A; Weil, D; El-Amraoui, A; Holme, RH; Rump, A; (2003) Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat Genet , 34 (4) pp. 421-428. 10.1038/ng1208.

McCormick, AL; Benjamin, R; Pizzey, A; Kyriakou, C; Nathwani, AC; (2003) Facilitation of lentivirus mediated gene transfer into primary human and murine progenitors by Antp peptide. In: BLOOD. (pp. 995A - 995A). AMER SOC HEMATOLOGY

McGregor, L; Makela, V; Darling, SM; Vrontou, S; Chalepakis, G; Roberts, C; Smart, N; (2003) Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. NAT GENET , 34 (2) 203 - 208.

McStay, M; Savage, K; Khan, K; Stubbs, M; Dhillon, AP; Caplin, M; (2003) Expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in the continuum from benign to malignant liver nodules. In: GASTROENTEROLOGY. (pp. A565 - A565). W B SAUNDERS CO

Mcgonigle, G; Glasow, A; Grier, D; Enver, T; Zelent, A; Thompson, A; (2003) Regulation of Hox genes by Il-3 in 32D and FDCP-mix cells. In: (Proceedings) 32nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology. (pp. p. 218). ELSEVIER SCIENCE INC

Mehta, A; (2003) Self-Assessment Colour Review of Clinical Haematology. [Book]. Manson Publishing

Mehta, A; (2003) The inner ear in Fabry disease. Acta Paediatrica , 92 p. 27.

Mehta, AB; Lewis, S; Laverey, C; (2003) Treatment of lysosomal storage disorders. BMJ (Clinical Research Ed.) , 30 (327) pp. 462-463.

Mela, M; Raimondo, ML; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; Patch, D; (2003) Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates. Journal of Hepatology , 38 129-.

Mela, M; Raimondo, ML; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; Patch, D; (2003) Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates. In: (pp. 129-).

Melo, JV; Tipping, AJ; (2003) Location matters... BLOOD , 102 (6) 1941 - 1942.

Meyer, T; McTiernan, A; Whelan, J; (2003) A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours. Sarcoma , 7 (1) pp. 13-17. 10.1080/1357714031000114192. Gold open access

Mitsiadis, TA; Angeli, I; James, C; Lendahl, U; Sharpe, PT; (2003) Role of Islet1 in the patterning of murine dentition. Development , 130 (18) pp. 4451-4460.

Moon, JCC; Sachdev, B; Elkington, AG; McKenna, WJ; Mehta, A; Pennell, DJ; Leed, PJ; (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease - Evidence for a disease specific abnormality of the myocardial interstitium. EUR HEART J , 24 (23) 2151 - 2155. 10.1016/j.ehj.2003.09.017.

Morris, EC; Rebello, P; Thomson, KJ; Peggs, KS; Kyrialkou, C; Goldstone, AH; Mackinnon, S; (2003) Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications. BLOOD , 102 (1) 404 - 406.

Morton, PE; Ng, TC; Roberts, SA; Vojnovic, B; Ameer-Beg, SM; (2003) Time resolved multiphoton imaging of the interaction between the PKC and NFκB signalling pathways. Proceedings of SPIE - The International Society for Optical Engineering , 5139 pp. 216-222.

Mumford, AD; McVey, JH; Morse, CV; Gomez, K; Steen, M; Norstrom, EA; Tuddenham, EG; (2003) Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol , 123 (3) pp. 496-501.

Mungall, AJ; Palmer, SA; Sims, SK; Edwards, CA; Ashurst, JL; Wilming, L; Jones, MC; (2003) The DNA sequence and analysis of human chromosome 6. NATURE , 425 (6960) 805 - U1. 10.1038/nature02055.

Murphy, DM; Dolbear, C; Moller, H; Whelan, JS; Pinkerton, CR; (2003) The incidence of cancer in adolescents and young adults in south east England: an analysis of Thames Cancer Registry data 1998-2000. In:

Mörner, A; Thomas, JA; Björling, E; Munson, PJ; Lucas, SB; McKnight, A; (2003) Productive HIV-2 infection in the brain is restricted to macrophages/microglia. AIDS , 17 (10) pp. 1451-1455. 10.1097/01.aids.0000076269.76134.c7.

N

Nash, M; Camilleri, R; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein 1 (anti-beta2GP1) polymorphism and antibodies to anti-beta2GP1. In: (Proceedings) International society of thrombosis and haemostasis.

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies. BRIT J HAEMATOL , 120 (3) 529 - 531.

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and anti-beta2GPI antibodies. British Journal of Haematology , 120 (3) pp. 529-531. 10.1046/j.1365-2141.2003.04130.x.

Nathan, PD; Hochhauser, D; (2003) Pathogenesis of Cancer. In: Kirk, RM and Ribbans, WJ, (eds.) Clinical Surgery in General. Charchill Livingstone: London.

Nathwani, AC; Ng, CY; Zhou, JF; Spence, Y; Nienhuis, AW; Davidoff, AM; (2003) Liver targeted delivery of recombinant adeno-associated virus (rAAV) serotype 5 vectors leads to sustained therapeutic expression of human factor IX (hFIX) in non-human primates previously sensitized to rAAV2 vectors. In: BLOOD. (pp. 493A - 493A). AMER SOC HEMATOLOGY

Newman, G; (2003) ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit. Lancet , 362 (9392) 1333-. 10.1016/S0140-6736(03)14602-8.

Newton, R; Ziegler, J; Ateenyi-Agaba, C; Bousarghin, L; Casabonne, D; Beral, V; Mbidde, E; (2003) The epidemiology of conjunctival squamous cell carcinoma in Uganda (vol 87, pg 301, 2002). BRIT J CANCER , 89 (2) 423 - 423. 10.1038/sj.bjc.6601128.

Newton, R; Ziegler, J; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. BRIT J CANCER , 89 (3) 502 - 504. 10.1038/sj.bjc.6601113.

Newton, R; Ziegler, J; Bourboulia, D; Casaborne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. INT J CANCER , 103 (2) 226 - 232. 10.1002/ijc.10817.

Ng, CY; Karimipoor, M; Zhou, JF; Lajmi, A; Zhong, WY; Spence, Y; Davidoff, AM; (2003) Highly pure recombinant adeno-associated viral (rAAV) vectors based on serotype 8 generated by a simple scalable chromatography method efficiently transduce murine liver. In: BLOOD. (pp. 501B - 502B). AMER SOC HEMATOLOGY

Nikitenko, LL; Smith, DM; Bicknell, R; Rees, MCP; (2003) Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia. FASEB J , 17 (9) 1499 - +. 10.1096/fj.02-0993fje.

Nooij, M; Lewis, I; Whelan, JS; Casak, S; Memon, M; Hogendoorn, P; Weeden, S; (2003) Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI). In:

Novelli, M; Cossu, A; Oukrif, D; Quaglia, A; Lakhani, S; Poulsom, R; Sasieni, P; (2003) X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proceedings of the National Academy of Sciences of the United States of America , 100 (6) pp. 3311-3314. 10.1073/pnas.0437825100.

Novelli, M; Cossu, A; Oukrif, D; Quaglia, A; Lakhani, S; Poulsom, R; Sasieni, P; (2003) X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. P NATL ACAD SCI USA , 100 (6) 3311 - 3314. 10.1073/pnas.0437825100.

Novelli, M; Preston, SL; Kyriakides, E; Oukrif, D; Tomlinson, I; Poulson, R; Wright, NA; (2003) Intra-villous adenomas in the duodenum of patients with familial adenomatous polyposis (FAP): Implications for the origins of adenomas and for the relevance of mouse models for intestinal neoplasia. In: JOURNAL OF PATHOLOGY. (pp. 5A - 5A). JOHN WILEY & SONS LTD

Novelli, M; Preston, SL; Kyriakides, E; Oukrif, D; Tomlinson, I; Poulson, R; Wright, NA; (2003) Intra-villous adenomas in the duodenum of patients with familial adenomatous polyposis (FAP): Implications for the origins of adenomas and for the relevance of mouse models for intestinal neoplasia. In: GASTROENTEROLOGY. (pp. A132 - A132). W B SAUNDERS CO

O

O'Connor, DL; Jacobs, J; Hall, R; Adamkin, D; Auestad, N; Castillo, M; Connor, WE; (2003) Growth and development of premature infants fed predominantly human milk, predominantly premature infant formula, or a combination of human milk and premature formula. J Pediatr Gastroenterol Nutr , 37 (4) pp. 437-446.

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol , 3 (4) pp. 317-330. 10.1038/nri1056.

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K-signalling in B- and T-cells: insights from gene-targeted mice. BIOCHEMICAL SOCIETY TRANSACTIONS , 31 pp. 270-274.

Ono, Y; Tomita, K; Matsuura, A; Nakagawa, T; Masukata, H; Uritani, M; Ushimaru, T; (2003) A novel allele of fission yeast rad11 that causes defects in DNA repair and telomere length regulation. Nucleic Acids Res , 31 (24) pp. 7141-7149. Gold open access

Orleans-Lindsay, JK; Deru, A; Craig, JIO; Prentice, HG; Lowdell, MW; (2003) In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. CLIN EXP IMMUNOL , 133 (3) 467 - 475.

Otth, C; Mendoza-Naranjo, A; Mujica, L; Zambrano, A; Concha, II; Maccioni, RB; (2003) Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease. NEUROREPORT , 14 (18) 2403 - 2409. 10.1097/01.wnr.0000099988.54721.3c.

Ouyang, Q; Wagner, WM; Wikby, A; Walter, S; Aubert, G; Dodi, A; Travers, P; (2003) Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. Journal of Clinical Immunology , 23 (4) pp. 247-257.

P

Paige, AJW; (2003) Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Cell Mol Life Sci , 60 (10) pp. 2147-2163. 10.1007/s00018-003-3027-6.

Pallier, C; (2003) Association of Chromatin Proteins High Mobility Group Box (HMGB) 1 and HMGB2 with Mitotic Chromosomes. Molecular Biology of the Cell , 14 (8) pp. 3414-3426. 10.1091/mbc.E02-09-0581.

Pamphilon, DH; Lowdell, MW; (2003) Stem cells and immunotherapy. TRANSFUSION MED , 13 (6) 323 - 324.

Parmar, M.K.; Ledermann, J.A.; Colombo, N.; du Bois, A.; Delaloye, J.F.; (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. The Lancet , 361 (9375) pp. 2099-2106. 10.1016/S0140-6736(03)13718-X.

Parmar, MKB; Ledermann, JA; Colombo, N; du Bois, A; Delaloye, JF; Kristensen, GB; Wheeler, S; (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. LANCET , 361 (9375) 2099 - 2106.

Paston, SJ; Dodi, IA; Travers, PJ; Madrigal, JA; (2003) The role of HLA-B alleles in CMV peptide epitope presentation. Is there a hierarchy in HLA presentation of CMV epitopes: 14th Annual BSHI conference abstracts. EUR J IMMUNOGEN , 30 (4) pp. 305-323.

Paston, SJ; Dodi, IA; Travers, PJ; Madrigal, JA; (2003) The role of HLA-B alleles in CMV peptide epitope presentation. Is there a hierarchy in HLA presentation of CMV epitopes: 14th Annual BSHI conference abstracts. European Journal of Immunogenetics , 30 (4) pp. 305-323.

Peggs, K; Mackinnon, S; (2003) Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia. NEW ENGL J MED , 348 (11) 1048 - 1050.

Peggs, K.S.; Mackinnon, S.; Williams, C.D.; D'Sa, S.; Thuraisundaram, D.; Kyriakou, C.; Morris, E.C.; (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Biology of Blood and Marrow Transplantation , 9 (4) pp. 257-265. 10.1053/bbmt.2003.50009.

Peggs, KS; Banerjee, L; Thomson, K; Mackinnon, S; (2003) Post-transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion. BONE MARROW TRANSPL , 31 (8) 725 - 726. 10.1038/sj.bmt.1703893.

Peggs, KS; Mackinnon, S; Williams, CD; D'Sa, S; Thuraisundaram, D; Kyriakou, C; Morris, EC; (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity. BIOL BLOOD MARROW TR , 9 (4) 257 - 265. 10.1053/bbmt.2003.50009.

Peggs, KS; Thomson, K; Chopra, R; Mahendra, P; Milligan, D; Parker, A; Hunter, A; (2003) Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. In: BLOOD. (pp. 198A - 199A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; D'Sa, S; Yong, K; Mackinnon, S; (2003) Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation. BRIT J HAEMATOL , 120 (1) 154 - 165.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S; (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. LANCET , 362 (9393) 1375 - 1377.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Moss, P; Goldstone, AH; Yong, K; (2003) Reconstitution of T-cell repertoire after autologous stem cell transplantation: Influence of CD34 selection and cytomegalovirus infection. BIOL BLOOD MARROW TR , 9 (3) 198 - 205. 10.1053/bbmt.2003.50010.

Penny, D; Henderson, SM; Brown, PJ; (2003) Raisin poisoning in a dog. The Veterinary record , 152 (10) p. 308.

Pepys, M.B.; Bybee, A.; Booth, D.R.; Bishop, M.T.; Will, R.G.; Little, A.-M; Prokupek, B.; (2003) MHC typing in variant Creutzfeldt-Jakob disease. The Lancet , 361 (9356) pp. 487-489. 10.1016/S0140-6736(03)12455-5.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) pp. 487-489.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) 487 - 489.

Pereira, SP; Falzon, M; Kocjan, G; Novelli, M; (2003) Prospective comparison of endoscopic ultrasound guided 22G fine needle aspiration (EUS-FNA) with 19G trucut needle biopsy (EUS-TNB). In: GUT. (pp. A26 - A26). BRITISH MED JOURNAL PUBL GROUP

Pileri, SA; Gaidano, G; Zinzani, PL; Falini, B; Gaulard, P; Zucca, E; Pieri, F; (2003) Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol , 162 (1) pp. 243-253.

Pileri, SA; Marafioti, T; Pozzobon, M; Sabattini, E; Ascani, S; Mancini, C; Piccioli, M; (2003) The different expression of key-molecules allows the easy subclassification of Hodgkin's lymphoma cases as well as their distinction from non-Hodgkin's lymphomas. Pathologica , 95 (5) 227-.

Plummer, R; Rees, C; Hughes, A; Beale, P; Highley, M; Trigo, J; Gokul, S; (2003) A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. CLIN CANCER RES , 9 (4) 1313 - 1322.

Pollara, G; Speidel, K; Samady, L; Rajpopat, M; McGrath, Y; Ledermann, J; Coffin, RS; (2003) Herpes simplex virus infection of dendritic cells: Balance among activation, inhibition, and immunity. J INFECT DIS , 187 (2) 165 - 178.

Porakishvili, N; Kulikova, N; Jewell, AP; Youinou, PY; Yong, K; Nathwani, A; Heelan, B; (2003) Preferential expression of CD180 by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated versus those using IgVh unmutated genes. In: (pp. S17-).

Porakishvili, N; Slovick, A; Jewell, AP; Youinou, PY; Nathwani, A; Yong, K; Stevenson, F; (2003) Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients. In: BLOOD. (pp. 432A - 432A). AMER SOC HEMATOLOGY

Porter, JB; Waldmeier, F; Bruin, G; Shah, F; Hazell, K; Warrington, S; Delage, S; (2003) Pharmacokinetics, metabolism and elimination of the iron chelator drug ICL670 in beta-thalassemia patients. In: BLOOD. (pp. 5B - 5B). AMER SOC HEMATOLOGY

Poulsom, R; Campbell, V; Jeffery, R; Hunt, T; Alison, MR; Dhillon, AP; Quaglia, AF; (2003) Hepatocytes bearing the Philadelphia chromosome: Evidence for transdifferentiation of bone marrow to liver without transplantation. In: JOURNAL OF PATHOLOGY. (pp. 4A - 4A). JOHN WILEY & SONS LTD

Poulsom, R; Campbell, V; Jeffery, R; Hunt, T; Alison, MR; Quaglia, A; Dhillon, AP; (2003) Hepatocytes bearing the Philadelphia chromosome reveal transdifferentiation of bone marrow to liver without transplantation. In: (pp. 205-).

Powles, T; Thirlwell, C; Nelson, M; Bower, M; (2003) Immune reconstitution inflammatory syndrome mimicking relapse of AIDS related lymphoma in patients with HIV 1 infection. LEUKEMIA LYMPHOMA , 44 (8) 1417 - 1419. 10.1080/1042819031000083280.

Pratten, J; Pasu, M; Jackson, G; Flanagan, A; Wilson, M; (2003) Modetting oral malodour in a longitudinal study. ARCH ORAL BIOL , 48 (11) 737 - 743. 10.1016/S0003-9969(03)00154-7.

Preiser, W; Brink, NS; Ayliffe, U; Peggs, KS; Mackinnon, S; Tedder, RS; Garson, JA; (2003) Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J CLIN VIROL , 26 (1) 49 - 59.

Presneau, N; Manderson, EN; Tonin, PN; (2003) The quest for a tumor suppressor gene phenotype. CURR MOL MED , 3 (7) 605 - 629.

Presneau, N; Mes-Masson, AM; Ge, B; Provencher, D; Hudson, TJ; Tonin, PN; (2003) Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines. ONCOGENE , 22 (10) 1568 - 1579. 10.1038/sj.onc.1206219.

Preston, SL; Wong, W; Chan, A; Poulsom, R; Jeffery, R; Goodlad, RA; Mandir, N; (2003) Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Research , 63 (13) pp. 3819-3825.

Puntervoll, P; Linding, R; Gemund, C; Chabanis-Davidson, S; Mattingsdal, M; Cameron, S; Martin, DM; (2003) ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Research , 31 (13) 3625 - 3630. 10.1093/nar/gkg545. Green open access
file

Q

Quaglia, A; Jutand, MA; Dhillon, A; Godfrey, A; Colombari, R; Togni, R; Dalla Palma, P;